# A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)

> **NCT02209766** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 86 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** D5884
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02209766
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2016-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209766, "A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02209766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*